Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, announces its participation in several financial conferences in the three coming months. During these events, the management team of Celyad will meet many institutional and retail investors to share with them the operational achievements made by the company during 2015 second half-year.

Meetings with institutional investors

  • Société Générale - Biotech & Medtech CEO conference: Paris, 5 November 2015.
  • KBC Biotech & Healthcare Seminar: New York, 9-10 November 2015.
  • Bank Degroof Petercam Healthcare CEO Seminar: Brussels, 25 November 2015.
  • Piper Jaffray Healthcare conference: New York, 1-2 December 2015.
  • ODDO Forum: Lyon, 7-8 January 2016.
  • JP Morgan Healthcare Conference: San Francisco, 11-15 January 2016.
  • BioMed Event by Invest Securities: Paris, 27 January 2016.

Meetings with retail investors:

  • Actionaria: Paris, 20-21 November 2015.
  • Finance Avenues: Brussels, 14 November 2015. 

Download press release(s)

Press release

234.13 Ko

Communiqué de presse

316.65 Ko

Celyad initiates the certification by the EMA of the non-clinical data of C-Cure®

Next News

Celyad initiates the certification by the EMA of the non-clinical data of C-Cure®